Profile

We are developing our technologies to address multiple opportunities within the global commercial agriculture industry, including extending the shelf life of perishable plant products, producing larger and leafier crops, increasing crop yields and reducing the harmful effects of environmental stresses, like drought.

We are also researching applications of our technologies which may address the many human diseases associated with suppressed or premature apoptosis, including cancer, glaucoma, and cardiovascular disease.

One of the main advantages of our patent pending genetic technologies is their broad applicability. Our technology has shown the ability to enhance a wide variety of crops, which could be implemented by multiple licensing partners on a worldwide scale. We have already made progress to this end with our existing commercial relationships. Likewise, we are researching the feasibility of using our technologies as therapeutics in a variety of human health conditions and plan to establish a similar licensing network for pharmaceuticals.

We believe that our technology could have a competitive advantage in treating apoptotic diseases because our technology regulates apoptosis by controlling all genetic pathways that trigger cell death. By mediating multiple pathways, the maximum benefit can be obtained, unlike competing technologies that act further "downstream" within individual pathways.

To take greatest advantage of our early stage discoveries, we have formed a highly focused and efficient R&D department headed by John Thompson, Ph.D., the inventor of our technology. This R&D takes place at several highly regarded academic institutions around North America. While most early-stage biotechnology companies spend millions on R&D, we are conducting top-notch research with relatively minimal cash burn by utilizing these institutions.

To protect the discoveries being generated by our researchers, we have a growing intellectual property estate that encompasses patent applications, both domestic and international, covering methods of controlling senescence in plants and regulating apoptosis for human health applications.


Back to Top